♦ 20 April 2018 ♦ [Relayed from the WHO website] Since the launch of the Global framework to eliminate human rabies transmitted by dogs by 2030 in 2015, WHO has worked with the Food and Agriculture Organization of the United Nations, the World Organisation for Animal Health, the Global Alliance for Rabies Control and other stakeholders and partners to prepare a global strategic plan. This includes a country-centric approach to support, empower and catalyse national entities to control and eliminate rabies. In this context, WHO convened its network of collaborating centres on rabies, specialized institutions, members of the WHO Expert Advisory Panel on Rabies, rabies experts and partners to review strategic and technical guidance on rabies to support implementation of country and regional programmes.  [Read more…]  

♦ 20 April 2018 ♦ [Relayed from the WHO website] In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. They summarize essential background information on diseases and vaccines and conclude with the current WHO position on the use of vaccines worldwide. The papers are reviewed by external experts and WHO staff, and reviewed and endorsed by the WHO Strategic Advisory Group of Experts (SAGE) on immunization. The GRADE methodology is used to systematically assess the quality of the available evidence. The SAGE decision-making process is reflected in the evidence-to-recommendation tables. [Read more…]  

♦ 25 April 2018 ♦ [Relayed from the ANSES website] “Basing itself on philosophical, social and legal interpretations of the concept of animal welfare, this Opinion proposes a definition of animal welfare that takes into account developments in scientific knowledge and summarises analyses by experts regarding the methods required for its assessment. The Opinion identifies numerous assessment grids aiming to objectively measure the conditions for animal welfare and encourages the development of specific tools depending on the species, development stage and environmental conditions of the animals. It provides an essential framework for ANSES's future research and expert appraisal work, and will serve as a basis for subsequent Opinions in this area. [Read more…]  

Abstract A Brucella suis biovar 1 infection was diagnosed in a dog without typical exposure risks, but the dog had been fed a raw meat-based diet (hare carcasses imported from Argentina). Track and trace investigations revealed that the most likely source of infection was the dog's raw meat diet.

Together with a significant upgrade of the MicrobesGenotyping web interface (version 1.4.0) the Brucella database has been updated in April 2018. It now contains genotype from 5611 strains, including more than 900 in silico deduced profiles. (source MLVA-NET)

KEY FACTS In 2015, 439 confirmed brucellosis cases were reported in the EU/EEA.  The notification rate in the EU/EEA was 0.1 cases per 100 000 population.  The highest rate was detected in 25–64-year-old males (0.14 cases per 100 000 population).  The notification rate was stable during the period 2011–2015.  The highest rates were reported in southern Member States (Greece, Bulgaria, and Portugal). (source ECDC: Annual Epidemiological report for 2015)

Abstract Brucellosis due to Brucella suis biovar 2 is one of the most important endemic diseases in wild boar (Sus scrofa) populations in Europe. The aim of the present study was to determine the seroprevalence of brucellosis in wild boars in the eastern part of Latvia. Wild boars killed by hunters in the period from January to April 2015 (n = 877) and from March to April in 2016 (n = 167) were examined for antibodies against B. suis by the Rose Bengal test (RBT), a complement fixation test (CFT), and by enzyme-linked immunosorbent assays. In 2015, 199 samples (22.7%) were positive by RBT and/or CFT while 36 samples (21.6%) were seropositive in 2016. Of the Brucella seropositive samples from 2015 and 2016 (n = 235), 162 (68.9%) were also seropositive to Yersinia enterocolitica. Considering cross-reactivity of serological tests, the seroprevalence of B. suis biovar 2 exposure in wild boars in the eastern part of Latvia was calculated to 14.0% in 2015 and 9.6% in 2016. From selected seropositive samples (42 in 2015 and 36 in 2016) total DNA was extracted and analyzed with an IS711-based nested polymerase chain reaction (PCR) assay. Species and biovar identification was conducted for bacteria isolated in monoculture from PCR positive samples by species specific primers and Bruce-ladder multiplex PCR. Brucella suis biovar 2 was isolated from 12/20 samples in 2015 and 9/9 samples in 2016. The average seroprevalence was relatively low compared to that found in certain other European countries. Males and females had an equal level of seropositivity, but a positive age-trend was observed for both males and females.

For any information, please contact Dr Guillaume Girault (guillaume.girault@anses.fr).    

DOI: 10.1016/j.prevetmed.2018.01.005